Elehear Beyond Pro vs Signia Pure C&G IX

The Elehear Beyond Pro is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.2/5 in our lab testing, placing it in the top 15% of the OTC category. Priced at $631, this behind-the-ear device has received HearAdvisor's Expert's Choice Award in both 2024 and 2025. In our testing, the Beyond Pro demonstrates notable strengths in music streaming, scoring 3.8/5—a solid result that sits 1.88 points above the category average. This makes it one of the stronger options for users who prioritize audio entertainment alongside speech clarity. Speech performance is also above average, with speech in quiet scoring 3.3/5 (+0.46 vs category) and speech in noise at 2.5/5 (+1.00 vs category). While the speech-in-noise score is above the category average, it remains mixed in absolute terms at 2.5/5. Feedback handling is excellent at 5.0/5. The primary trade-off is own-voice comfort, which scores 1.2/5—a low result that falls 1.31 points below the category average. Users who are sensitive to how their own voice sounds may find this noticeable. The Beyond Pro is best suited for OTC shoppers who want strong streaming quality and solid speech performance without professional fitting. It competes in a price range that includes higher-scoring options like the Yeasound RIC800 and Sony CRE-E10, so prospective buyers may want to compare based on their priorities. Features include rechargeable batteries, iPhone and Android streaming, and hands-free capability.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.